Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

<p>Abstract</p> <p>Background</p> <p>There is no effective treatment strategy for advanced castration-resistant prostate cancer. Although Docetaxel (Taxotere<sup>®</sup>) represents the most active chemotherapeutic agent it only gives a modest survival advan...

Full description

Bibliographic Details
Published in:Molecular Cancer
Main Authors: Rani Sweta, Corcoran Claire, Devery Aoife, O'Connor Robert, O'Connor Darran, Gallagher William M, Mulrane Laoighse, Fan Yue, Dowling Catherine, Prencipe Maria, O'Neill Amanda J, O'Driscoll Lorraine, Fitzpatrick John M, Watson R William G
Format: Article
Language:English
Published: BMC 2011-10-01
Subjects:
Docetaxel
Prostate
NF-κB
Apoptosis
Viability
Online Access:http://www.molecular-cancer.com/content/10/1/126

Internet

http://www.molecular-cancer.com/content/10/1/126

Similar Items